CTLA4 and psoriatic arthritis: In a younger group of patients with a complex phenotype including CVID, thrombocytopenia, psoriatic arthritis and enteropathy, the detection of a mutation in CTLA4 prompted us to treat them with abatacept, with benefits [41].